Yes, you can get your flu and COVID-19 shots at the same time. Don’t call them boosters — they’re not just another dose of last year’s protection. The coronavirus and influenza are escape artists that ...

Invizyne Technologies (IZTC.) has priced its initial public offering to raise $15M in gross proceeds. The biomanufacturing ...

Pfizer-BioNTech, Johnson and Johnson, and Moderna said their vaccines prevented severe illness ... COVID-19 cases in the U.S. beginning in June 2021. Surges in cases in the fall of 2021, even in ...

Kamala Harris lost 2024 US election, 10 large-cap stocks performed poorly: Moderna, Honda, Akamai, ADS, AstraZeneca, ...

Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...

He estimates COVID-19 vaccine sales next year will fall to ~$2.0B, lower than the $2.6 billion predicted ... Foroohar lowered ...

Shares of Moderna Inc. MRNA shed 6.86% to $46.83 Friday, on what proved to be an all-around favorable trading session for the ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Investors are digesting a fresh interest rate cut from the Federal Reserve as the impact of Trump's expected policies also remains in focus.

A long negative candle was formed on the daily chart after the upside bounce of the last two sessions. The crucial overhead ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...